<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Brain Spine</journal-id><journal-id journal-id-type="iso-abbrev">Brain Spine</journal-id><journal-id journal-id-type="pmc-domain-id">4303</journal-id><journal-id journal-id-type="pmc-domain">bas</journal-id><journal-title-group><journal-title>Brain &amp; Spine</journal-title></journal-title-group><issn pub-type="epub">2772-5294</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11718286</article-id><article-id pub-id-type="pmcid-ver">PMC11718286.1</article-id><article-id pub-id-type="pmcaid">11718286</article-id><article-id pub-id-type="pmcaiid">11718286</article-id><article-id pub-id-type="pmid">39802870</article-id><article-id pub-id-type="doi">10.1016/j.bas.2024.104164</article-id><article-id pub-id-type="pii">S2772-5294(24)01420-6</article-id><article-id pub-id-type="publisher-id">104164</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Predictive factors for ventriculoperitoneal shunt placement in aneurysmatic subarachnoid hemorrhages</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name name-style="western"><surname>Pereira</surname><given-names initials="R">Renato</given-names></name><email>renato.sousa.pereira@ulsb.min-saude.pt</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="fn1" ref-type="fn">1</xref><xref rid="cor1" ref-type="corresp">&#8727;</xref></contrib><contrib contrib-type="author" id="au2"><name name-style="western"><surname>Torres</surname><given-names initials="B">Beatriz</given-names></name><email>a92570@alunos.uminho.pt</email><xref rid="aff2" ref-type="aff">b</xref><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au3"><name name-style="western"><surname>Nogueira</surname><given-names initials="J">Jo&#227;o</given-names></name><email>joao.pedro.nogueira@ulsb.min-saude.pt</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au4"><name name-style="western"><surname>Coimbra</surname><given-names initials="F">Frederica</given-names></name><email>frederica.coimbra@ulsb.min-saude.pt</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au5"><name name-style="western"><surname>Afonso</surname><given-names initials="M">Miguel</given-names></name><email>miguel.filipe@ulsb.min-saude.pt</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au6"><name name-style="western"><surname>Alegria</surname><given-names initials="C">Carlos</given-names></name><email>carlos.alegria@ulsb.min-saude.pt</email><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au7"><name name-style="western"><surname>Marques</surname><given-names initials="R">Renata</given-names></name><email>renata.marques@ulsb.min-saude.pt</email><xref rid="aff1" ref-type="aff">a</xref><xref rid="PC_fnvGbXWqmKOv" ref-type="fn">2</xref></contrib><aff id="aff1"><label>a</label>Department of Neurosurgery, Hospital de Braga, R. das Sete Fontes, 4710-243, Braga, Portugal</aff><aff id="aff2"><label>b</label>School of Medicine, Life and Health Sciences Research Institute (ICVS), Universidade do Minho, Campus de Gualtar, 4710-057, Braga, Portugal</aff><aff id="aff3"><label>c</label>Laborat&#243;rio Associado, Instituto de Investiga&#231;&#227;o em Ci&#234;ncias da Vida e Sa&#250;de (ICVS), Guimar&#227;es, Universidade do Minho, Campus de Gualtar, 4710-057, Braga, Portugal</aff></contrib-group><author-notes><corresp id="cor1"><label>&#8727;</label>Corresponding author. <email>renato.sousa.pereira@ulsb.min-saude.pt</email></corresp><fn id="fn1"><label>1</label><p id="ntpara0010">The first two authors contributed equally to this work.</p></fn><fn id="PC_fnvGbXWqmKOv"><label>2</label><p id="notep0005d">Study coordinator.</p></fn></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>12</day><month>12</month><year>2024</year></pub-date><volume>5</volume><issue-id pub-id-type="pmc-issue-id">477932</issue-id><elocation-id>104164</elocation-id><history><date date-type="received"><day>28</day><month>9</month><year>2024</year></date><date date-type="rev-recd"><day>9</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>11</day><month>12</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>12</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>10</day><month>01</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-01-13 11:25:14.103"><day>13</day><month>01</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2024 The Authors</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract id="abs0010"><sec><title>Introduction</title><p>Aneurysmatic subarachnoid hemorrhages (aSAH) are life-threatening events with high mortality and morbidity. Hydrocephalus is a common complication, initially managed with an external ventricular drain (EVD). Persistent hydrocephalus often requires ventriculoperitoneal shunt (VPS) placement to relieve intracranial pressure and prevent further neurological damage.</p></sec><sec><title>Research question</title><p>What factors predict the need for VPS placement in patients with aSAH, and how does a new predictive model compare to the Mayo Age, Grades, EVD score (MAGE score)?</p></sec><sec><title>Materials and methods</title><p>A retrospective study of 105 patients with aSAH treated with EVD between 2014 and 2023 was conducted. Patients were divided into two groups: those requiring VPS (n=&#160;45) and those not requiring VPS (n=&#160;60). Sociodemographic, clinical, and treatment variables were analysed, and a new predictive model (SAH-VP) was developed and compared to the MAGE score.</p></sec><sec><title>Results</title><p>Patients who required VPS had higher WFNS scores on admission (p=&#160;0.045), more infections requiring antibiotics (p=&#160;0.002), more failed weaning attempts (p=&#160;0.004), more failed closure attempts (p=&#160;0.002), and longer EVD use (p&lt;&#160;0.01). The new SAH-VP model demonstrated an area under the curve (AUC) of 0.800.</p></sec><sec><title>Discussion and conclusion</title><p>There is no consensus on the factors predicting VPS need in SAH patients. This study identified key predictors and developed a new predictive model, SAH-VP, which could improve patient management by identifying those at higher risk of requiring VPS, offering an alternative to the existing MAGE score.</p></sec></abstract><abstract abstract-type="author-highlights" id="abs0015"><title>HIGHLIGHTS</title><p><list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#8226;</label><p id="p0010">Aneurysmatic SAH often cause hydrocephalus, that may require definitive LCR derivation</p></list-item><list-item id="u0015"><label>&#8226;</label><p id="p0015">Key predictors for VPS in aSHA are higher WFNS scores, infections, longer EVD use, failed closure and weaning tries, which were used to create SAH-VP score</p></list-item><list-item id="u0020"><label>&#8226;</label><p id="p0020">SAH-VP score identifies VPS need in aSAH with an AUC of 0.800.</p></list-item><list-item id="u0025"><label>&#8226;</label><p id="p0025">Using SAH-VP improves management by identifying patients with high-risk for VPS earlier.</p></list-item></list></p></abstract><kwd-group id="kwrds0010"><title>Keywords</title><kwd>Aneurismatic subarachnoid hemorrhage</kwd><kwd>Hydrocephalus</kwd><kwd>External ventricular drain</kwd><kwd>Ventriculoperitoneal shunt</kwd><kwd>Hydrocephalus prognosis</kwd><kwd>MAGE score</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta><notes><p id="misc0010">Handling Editor: Dr W Peul</p></notes></front><body><p id="p0030">
<table-wrap position="float" id="undtbl1" orientation="portrait"><caption><p>LIST OF ABBREVIATIONS</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="1" rowspan="1"><bold>aSAH</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Aneurismatic Subarachnoid Hemorrage</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>AUC</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Area Under Curve</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>CI</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Confidence Interval</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>CSF</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Cerebrospinal fluid</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>CT</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Computed Tomography</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>EVD</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">External Ventricular Drain</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>GCS</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Glasgow Come Scale</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>HB</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Hospital de Braga</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>ICU</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Intensive Care Unit</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>M</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Mean</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>MAGE</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Mayo Age, Grades, EVD</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>Mdn</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Median</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>mRS</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Modified Rankin Scale</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>mFisher</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Modified Fisher</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>N</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Absolute Frequency</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>NCCU</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Neurocritical Care Unit</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>OR</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Odds Ratio</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>p-value</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Level of statistical significance</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>T</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">T test for Independent Samples</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>SAH</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Subarachnoid hemorrages</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>sSAH</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Spontaneous Subarachnoid hemorrages</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>SD</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Standard deviation</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>SPSS&#174;</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Statistical Package for the Social Sciences</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>VPS</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">Ventriculoperitoneal shunt</italic></td></tr><tr><td align="left" colspan="1" rowspan="1"><bold>WFNS</bold></td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">World Federation of Neurosurgeons</italic></td></tr></tbody></table></table-wrap>
</p><sec id="sec1"><label>1</label><title>Introduction</title><p id="p0035">Spontaneous subarachnoid hemorrhages (sSAH) account for 2&#8211;7% of all strokes (<xref rid="bib7" ref-type="bibr">De Rooij et al., 2007</xref>; <xref rid="bib10" ref-type="bibr">Etminan et al., 2019</xref>; <xref rid="bib23" ref-type="bibr">Maher et al., 2020</xref>), with a global incidence of 6&#8211;8 cases per 100.000 people annually (<xref rid="bib7" ref-type="bibr">De Rooij et al., 2007</xref>; <xref rid="bib10" ref-type="bibr">Etminan et al., 2019</xref>; <xref rid="bib23" ref-type="bibr">Maher et al., 2020</xref>; <xref rid="bib17" ref-type="bibr">Hoh et al., 2023</xref>; <xref rid="bib26" ref-type="bibr">Molyneux, 2002</xref>). Despite its rarity, sSAH is associated with high mortality and significant long-term morbidity (<xref rid="bib17" ref-type="bibr">Hoh et al., 2023</xref>; <xref rid="bib26" ref-type="bibr">Molyneux, 2002</xref>; <xref rid="bib21" ref-type="bibr">Long et al., 2017</xref>).</p><p id="p0040">The leading cause of spontaneous SAH is the rupture of intracerebral aneurysms, aneurysmatic SAH (aSAH), responsible for 85% of cases (<xref rid="bib23" ref-type="bibr">Maher et al., 2020</xref>; <xref rid="bib22" ref-type="bibr">Macdonald and Schweizer, 2017</xref>). Other causes include drug abuse (<xref rid="bib24" ref-type="bibr">McEvoy, 2000</xref>), coagulation disorders, arteriovenous malformations, and tumors (<xref rid="bib37" ref-type="bibr">Sweeney et al., 2016</xref>; <xref rid="bib31" ref-type="bibr">Rinkel et al., 1993</xref>). Major risk factors include smoking, hypertension, alcohol abuse and advanced age, particularly in women (<xref rid="bib10" ref-type="bibr">Etminan et al., 2019</xref>; <xref rid="bib12" ref-type="bibr">Feigin et al., 2005</xref>; <xref rid="bib42" ref-type="bibr">Vivancos et al., 2014</xref>; <xref rid="bib16" ref-type="bibr">Harrison et al., 2023</xref>). SAH often presents with a sudden, severe headache, nausea, vomiting, neck stiffness, and altered consciousness (<xref rid="bib45" ref-type="bibr">Ziu et al., 2024</xref>; <xref rid="bib40" ref-type="bibr">Togha et al., 2009</xref>). CT scans are the primary diagnostic tool (<xref rid="bib17" ref-type="bibr">Hoh et al., 2023</xref>; <xref rid="bib21" ref-type="bibr">Long et al., 2017</xref>; <xref rid="bib45" ref-type="bibr">Ziu et al., 2024</xref>). Severity is evaluated using the <xref rid="bib18" ref-type="bibr">Hunt and Hess (1968)</xref>, World Federation of Neurosurgeons (WFNS) (<xref rid="bib39" ref-type="bibr">Teasdale et al., 1988</xref>) and the modified Fisher (mFisher) (<xref rid="bib14" ref-type="bibr">Frontera et al., 2006</xref>) scales, which help predict patient prognosis (<xref rid="bib17" ref-type="bibr">Hoh et al., 2023</xref>).</p><p id="p0045">Hydrocephalus, a common complication, affects 20&#8211;30% of aSAH patients (<xref rid="bib4" ref-type="bibr">Chen et al., 2017</xref>; <xref rid="bib33" ref-type="bibr">Shaikh et al., 2023</xref>) and is characterized by excess cerebrospinal fluid (CSF) in the brain (<xref rid="bib29" ref-type="bibr">Rekate, 2009</xref>), which may require intervention with external ventricular drains (EVDs) or ventriculoperitoneal shunts (VPS) if persistent (<xref rid="bib4" ref-type="bibr">Chen et al., 2017</xref>; <xref rid="bib5" ref-type="bibr">Chung et al., 2018</xref>; <xref rid="bib19" ref-type="bibr">Koleva and De Jesus, 2024</xref>; <xref rid="bib13" ref-type="bibr">Fowler et al., 2024</xref>; <xref rid="bib36" ref-type="bibr">Steinke et al., 1987</xref>).</p><p id="p0050">Recent advancements include the &#8220;Mayo Age, Grades, EVD score&#8221;- The MAGE score <xref rid="tbl1" ref-type="table">Table 1</xref> (<xref rid="bib28" ref-type="bibr">Perry et al., 2020</xref>), a model developed by the Mayo Clinic to predict the need for VPS after SAH. This model incorporates factors such as age, the modified Fisher scale, the WFNS scale, mean daily EVD output, and the number of weaning and closure attempts.<table-wrap position="float" id="tbl1" orientation="portrait"><label>Table 1</label><caption><p>MAGE score.</p></caption><alt-text id="alttext0015">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Variable</th><th colspan="1" rowspan="1">Points</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age &#8805; 65</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">mFisher 2 or 4</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">WFNS 5</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">Mean daily EVD output &#8805; 200&#160;ml, days 0&#8211;2</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">Wean failures &#8805;2</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">Any clamp failure</td><td align="left" colspan="1" rowspan="1">1</td></tr></tbody></table><table-wrap-foot><fn><p>Adapted from: Perry A, Graffeo CS, Kleinstern G, Carlstrom LP, Link MJ, Rabinstein AA. Quantitative Modeling of External Ventricular Drain Output to Predict Shunt Dependency in Aneurysmal Subarachnoid Hemorrhage: Cohort Study. Neurocrit Care. 2020; 33(1).</p></fn></table-wrap-foot></table-wrap></p><p id="p0055">This study aims to understand the factors that may predict the need for VPS placement for the management of hydrocephalus in cases of aSAH and create a new predictive model. We also compare our new model to the MAGE score.</p></sec><sec id="sec2"><label>2</label><title>Methods</title><sec id="sec2.1"><label>2.1</label><title>Study design and population</title><p id="p0060">This retrospective cohort study included patients diagnosed with aSAH who were admitted to the Neurosurgery Department at Hospital de Braga (HB) between January 2014 and December 2023. The inclusion criteria required patients to have a diagnosis of aSAH, admission to HB during the specified period and the need for EVD to manage hydrocephalus. Patients with &lt;18 years old would be excluded, however, all participants met the inclusion criteria.</p></sec><sec id="sec2.2"><label>2.2</label><title>Data collection</title><p id="p0065">Most of the data were obtained from electronic medical records using the B-Simple&#174; platform, while Modified Rankin Scale (mRS) scores were gathered using Glintt&#174;. The data was entered into a Microsoft Office Excel&#174; database. Following data collection, the data was anonymized to ensure confidentiality.</p><p id="p0070">We collected data encompassing sociodemographic characteristics, clinical information, and imaging findings, including mFisher, WFNS, and Hunt and Hess scores. Additionally, we gathered data on EVD parameters, such as the number of days in use, management strategies, daily output values, and complications. Finally, patient outcomes were assessed using the mRS scale.</p></sec><sec id="sec2.3"><label>2.3</label><title>Endpoints</title><p id="p0075">Following data collection, we analysed factors significantly associated with the need for a VPS and incorporated them into the development of a novel predictive model. This model was applied to our study population. The MAGE score was also applied in our population, to evaluate model strength and to later compare it to our own model. We calculated outcome probabilities for each score and evaluated its performance using ROC curve analysis, alongside sensitivity and specificity metrics. A similar performance analysis was conducted for the MAGE score, enabling a direct comparison between the two predictive models.</p></sec><sec id="sec2.4"><label>2.4</label><title>Statistical analysis</title><p id="p0080">Data analysis was performed using IBM SPSS Statistics&#174; software (version 30.0). A significance threshold of p&#160;&lt;&#160;0,05 was used, and 95% confidence intervals (CI) were calculated. The normality of continuous variables was checked using standard tests and visual inspections.</p><p id="p0085">Descriptive statistics included frequencies and percentages for categorical variables and means with standard deviations for normally distributed continuous variables. Non-normally distributed continuous variables were described with medians. Inferential statistics involved Pearson's Chi-square test for associations among categorical variables, with Fisher's Exact Test applied as needed.</p><p id="p0090">For comparing VPS dependency, Student's t-test was used for normally distributed numeric variables, with Levene's test for equality of variances. Non-normally distributed variables were analysed with the Mann-Whitney <italic toggle="yes">U</italic> test. Logistic regression models assessed predictors of VPS placement, with odds ratio (OR) and their significance evaluated.</p><p id="p0095">Model performance was gauged using receiver-operator curve (ROC) analysis, plotting sensitivity against 1-specificity. The area under the ROC curve (AUC) was used to measure discrimination, where an AUC&gt;0,5 indicates effective performance (<xref rid="appsec1" ref-type="sec">Appendix A</xref>) (<xref rid="bib6" ref-type="bibr">Corbacioglu and Aksel, 2023</xref>). The Hosmer-Lemeshow Test assessed model fit, with a higher p-value suggesting a good fit.</p></sec></sec><sec id="sec3"><label>3</label><title>Results</title><p id="p0100">From a total population of 450 patients admitted for spontaneous SAH at HB from 2014 to 2023, 286 (63.6%) were due to aneurysmatic rupture. 105 (36.7%) of those underwent EVD placement for acute hydrocephalus management. Out of these patients, 45 (42.8%) required VPS. Patients with aSAH who did not require EVD were not considered for this study, but in that group 9 patients (5.0%) ended up needing VPS in the long term.</p><p id="p0105">The majority of these patients were women (72.5%), with similar gender proportions across both groups. The mean age was 63 years, and hypertension was present in 54.3% of cases. Baseline sociodemographic characteristics, as detailed in <xref rid="tbl2" ref-type="table">Table 2</xref>, showed no significant differences between the VPS and non-VPS groups.<table-wrap position="float" id="tbl2" orientation="portrait"><label>Table 2</label><caption><p>Sociodemographic statistical analysis between patients submitted to VPS and no VPS.</p></caption><alt-text id="alttext0020">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" colspan="1"/><th colspan="2" rowspan="2" align="center">All (n&#160;=&#160;105)<hr/></th><th colspan="5" align="center" rowspan="1">Submitted to VPS placement<hr/></th><th rowspan="3" align="center" colspan="1">P value</th></tr><tr><th colspan="3" align="center" rowspan="1">No (n&#160;=&#160;60)<break/>(n&#160;=&#160;80)<hr/></th><th colspan="2" align="center" rowspan="1">Yes (n&#160;=&#160;45)<break/>(n&#160;=&#160;55)<hr/></th></tr><tr><th align="center" colspan="1" rowspan="1">n</th><th align="center" colspan="1" rowspan="1">%</th><th align="center" colspan="1" rowspan="1">n</th><th colspan="2" align="center" rowspan="1">%</th><th align="center" colspan="1" rowspan="1">n</th><th align="center" colspan="1" rowspan="1">%</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age (mean&#160;&#177;&#160;sd))</td><td align="center" colspan="1" rowspan="1">63.2</td><td align="center" colspan="1" rowspan="1">(&#177;14.1)</td><td align="center" colspan="1" rowspan="1">63.1</td><td colspan="2" align="center" rowspan="1">(&#177;14.3)</td><td align="center" colspan="1" rowspan="1">63.4</td><td align="center" colspan="1" rowspan="1">(&#177;14.0)</td><td align="center" colspan="1" rowspan="1">0.899</td></tr><tr><td align="left" colspan="1" rowspan="1">Sex (Female)</td><td align="center" colspan="1" rowspan="1">79</td><td align="center" colspan="1" rowspan="1">75.2</td><td align="center" colspan="1" rowspan="1">43</td><td colspan="2" align="center" rowspan="1">71.7</td><td align="center" colspan="1" rowspan="1">36</td><td align="center" colspan="1" rowspan="1">80.0</td><td align="center" colspan="1" rowspan="1">0.328</td></tr><tr><td colspan="9" align="left" rowspan="1">Risk Factors</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Hypertension</td><td align="center" colspan="1" rowspan="1">57</td><td align="center" colspan="1" rowspan="1">54.3</td><td align="center" colspan="1" rowspan="1">32</td><td colspan="2" align="center" rowspan="1">53.3</td><td align="center" colspan="1" rowspan="1">25</td><td align="center" colspan="1" rowspan="1">55.6</td><td align="center" colspan="1" rowspan="1">0.821</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Active nicotine use</td><td align="center" colspan="1" rowspan="1">24</td><td align="center" colspan="1" rowspan="1">22.9</td><td align="center" colspan="1" rowspan="1">17</td><td colspan="2" align="center" rowspan="1">26.2</td><td align="center" colspan="1" rowspan="1">7</td><td align="center" colspan="1" rowspan="1">15.6</td><td align="center" colspan="1" rowspan="1">0,123</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Alcohol consumption</td><td align="center" colspan="1" rowspan="1">9</td><td align="center" colspan="1" rowspan="1">8.6</td><td align="center" colspan="1" rowspan="1">6</td><td colspan="2" align="center" rowspan="1">9.2</td><td align="center" colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">6.7</td><td align="center" colspan="1" rowspan="1">0.729</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Anti-platelet drugs</td><td align="center" colspan="1" rowspan="1">11</td><td align="center" colspan="1" rowspan="1">10.5</td><td align="center" colspan="1" rowspan="1">3</td><td colspan="2" align="center" rowspan="1">4.6</td><td align="center" colspan="1" rowspan="1">8</td><td align="center" colspan="1" rowspan="1">17.8</td><td align="center" colspan="1" rowspan="1">0.060</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Anticoagulants</td><td align="center" colspan="1" rowspan="1">6</td><td align="center" colspan="1" rowspan="1">5.7</td><td align="center" colspan="1" rowspan="1">3</td><td colspan="2" align="center" rowspan="1">4.6</td><td align="center" colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">6.7</td><td align="center" colspan="1" rowspan="1">0.693</td></tr><tr><td align="left" colspan="1" rowspan="1">Admission Unit</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="2" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td align="center" colspan="1" rowspan="1">0.723</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;ICU</td><td align="center" colspan="1" rowspan="1">37</td><td align="center" colspan="1" rowspan="1">34.5</td><td align="center" colspan="1" rowspan="1">22</td><td colspan="2" align="center" rowspan="1">36.6</td><td align="center" colspan="1" rowspan="1">15</td><td align="center" colspan="1" rowspan="1">33.3</td><td colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160;NCCU</td><td align="center" colspan="1" rowspan="1">68</td><td align="center" colspan="1" rowspan="1">64.5</td><td align="center" colspan="1" rowspan="1">38</td><td colspan="2" align="center" rowspan="1">63.3</td><td align="center" colspan="1" rowspan="1">30</td><td align="center" colspan="1" rowspan="1">66.7</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="9" align="left" rowspan="1">Clinical and Imagiologic Assessment</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;WFNS at presentation (median (range))</td><td align="center" colspan="1" rowspan="1">4</td><td align="center" colspan="1" rowspan="1">1&#8211;5</td><td align="center" colspan="1" rowspan="1">3</td><td colspan="2" align="center" rowspan="1">1&#8211;5</td><td align="center" colspan="1" rowspan="1">4</td><td align="center" colspan="1" rowspan="1">1&#8211;5</td><td align="center" colspan="1" rowspan="1">0.045</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;WFNS &#8805;2</td><td align="center" colspan="1" rowspan="1">80</td><td align="center" colspan="1" rowspan="1">76.2</td><td align="center" colspan="1" rowspan="1">42</td><td colspan="2" align="center" rowspan="1">70.0</td><td align="center" colspan="1" rowspan="1">38</td><td align="center" colspan="1" rowspan="1">84.4</td><td align="center" colspan="1" rowspan="1">0.085</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;WFNS &#8805;3</td><td align="center" colspan="1" rowspan="1">67</td><td align="center" colspan="1" rowspan="1">63.8</td><td align="center" colspan="1" rowspan="1">35</td><td colspan="2" align="center" rowspan="1">58.3</td><td align="center" colspan="1" rowspan="1">32</td><td align="center" colspan="1" rowspan="1">71.1</td><td align="center" colspan="1" rowspan="1">0.178</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;WFNS &#8805;4</td><td align="center" colspan="1" rowspan="1">53</td><td align="center" colspan="1" rowspan="1">50.5</td><td align="center" colspan="1" rowspan="1">25</td><td colspan="2" align="center" rowspan="1">41.7</td><td align="center" colspan="1" rowspan="1">28</td><td align="center" colspan="1" rowspan="1">62.2</td><td align="center" colspan="1" rowspan="1">0.037</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;WFNS 5</td><td align="center" colspan="1" rowspan="1">22</td><td align="center" colspan="1" rowspan="1">21.0</td><td align="center" colspan="1" rowspan="1">10</td><td colspan="2" align="center" rowspan="1">16.7</td><td align="center" colspan="1" rowspan="1">12</td><td align="center" colspan="1" rowspan="1">26.7</td><td align="center" colspan="1" rowspan="1">0.123</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Hunt and Hess (median (range))</td><td align="center" colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">1&#8211;5</td><td align="center" colspan="1" rowspan="1">1</td><td colspan="2" align="center" rowspan="1">1&#8211;5</td><td align="center" colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">1&#8211;5</td><td align="center" colspan="1" rowspan="1">0.125</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;mFISHER, cont scale (median (range)</td><td align="center" colspan="1" rowspan="1">4</td><td align="center" colspan="1" rowspan="1">1&#8211;4</td><td align="center" colspan="1" rowspan="1">4</td><td colspan="2" align="center" rowspan="1">1&#8211;4</td><td align="center" colspan="1" rowspan="1">4</td><td align="center" colspan="1" rowspan="1">1&#8211;4</td><td align="center" colspan="1" rowspan="1">0.421</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;mFISHER &#8805;3</td><td align="center" colspan="1" rowspan="1">90</td><td align="center" colspan="1" rowspan="1">85.7</td><td align="center" colspan="1" rowspan="1">50</td><td colspan="2" align="center" rowspan="1">83.3</td><td align="center" colspan="1" rowspan="1">40</td><td align="center" colspan="1" rowspan="1">88.9</td><td align="center" colspan="1" rowspan="1">0.421</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;mFISHER 2 or 4</td><td align="center" colspan="1" rowspan="1">94</td><td align="center" colspan="1" rowspan="1">89.5</td><td align="center" colspan="1" rowspan="1">53</td><td colspan="2" align="center" rowspan="1">88.3</td><td align="center" colspan="1" rowspan="1">41</td><td align="center" colspan="1" rowspan="1">91.1</td><td align="center" colspan="1" rowspan="1">0.865</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;mFISHER 4</td><td align="center" colspan="1" rowspan="1">80</td><td align="center" colspan="1" rowspan="1">76.2</td><td align="center" colspan="1" rowspan="1">44</td><td colspan="2" align="center" rowspan="1">73.3</td><td align="center" colspan="1" rowspan="1">36</td><td align="center" colspan="1" rowspan="1">80.0</td><td align="center" colspan="1" rowspan="1">0.427</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Anterior circulation aneurysm</td><td align="center" colspan="1" rowspan="1">63</td><td align="center" colspan="1" rowspan="1">60</td><td align="center" colspan="1" rowspan="1">35</td><td colspan="2" align="center" rowspan="1">58.3</td><td align="center" colspan="1" rowspan="1">28</td><td align="center" colspan="1" rowspan="1">62,2</td><td align="center" colspan="1" rowspan="1">0.687</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Number of aneurysms (median (range))</td><td align="center" colspan="1" rowspan="1">1</td><td align="center" colspan="1" rowspan="1">1&#8211;3</td><td align="center" colspan="1" rowspan="1">1</td><td colspan="2" align="center" rowspan="1">1&#8211;3</td><td align="center" colspan="1" rowspan="1">1</td><td align="center" colspan="1" rowspan="1">1&#8211;3</td><td align="center" colspan="1" rowspan="1">0.741</td></tr><tr><td align="left" colspan="1" rowspan="1">Primary treatment modality of aneurysm:</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td rowspan="4" align="center" colspan="1">0,294</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Endovascular</td><td align="center" colspan="1" rowspan="1">50</td><td align="center" colspan="1" rowspan="1">47,6</td><td align="center" colspan="1" rowspan="1">31</td><td colspan="2" align="center" rowspan="1">51,7</td><td align="center" colspan="1" rowspan="1">19</td><td align="center" colspan="1" rowspan="1">42,2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Surgery</td><td align="center" colspan="1" rowspan="1">34</td><td align="center" colspan="1" rowspan="1">32,4</td><td align="center" colspan="1" rowspan="1">16</td><td colspan="2" align="center" rowspan="1">26,7</td><td align="center" colspan="1" rowspan="1">18</td><td align="center" colspan="1" rowspan="1">40</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Both</td><td align="center" colspan="1" rowspan="1">12</td><td align="center" colspan="1" rowspan="1">11,4</td><td align="center" colspan="1" rowspan="1">6</td><td colspan="2" align="center" rowspan="1">10</td><td align="center" colspan="1" rowspan="1">6</td><td align="center" colspan="1" rowspan="1">13,3</td></tr><tr><td colspan="9" align="left" rowspan="1">Complications following admission</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Aneurysm Re-bleed</td><td align="center" colspan="1" rowspan="1">8</td><td align="center" colspan="1" rowspan="1">7.6</td><td align="center" colspan="1" rowspan="1">5</td><td colspan="2" align="center" rowspan="1">8.3</td><td align="center" colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">6.7</td><td align="center" colspan="1" rowspan="1">1.000</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Intraparenchymatous hematoma</td><td align="center" colspan="1" rowspan="1">8</td><td align="center" colspan="1" rowspan="1">7.6</td><td align="center" colspan="1" rowspan="1">4</td><td colspan="2" align="center" rowspan="1">6.7</td><td align="center" colspan="1" rowspan="1">4</td><td align="center" colspan="1" rowspan="1">8.8</td><td align="center" colspan="1" rowspan="1">0.671</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Intraventricular hematoma</td><td align="center" colspan="1" rowspan="1">2</td><td align="center" colspan="1" rowspan="1">1.9</td><td align="center" colspan="1" rowspan="1">1</td><td colspan="2" align="center" rowspan="1">1.7</td><td align="center" colspan="1" rowspan="1">1</td><td align="center" colspan="1" rowspan="1">2.2</td><td align="center" colspan="1" rowspan="1">1.000</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Epileptic crisis (inaugural)</td><td align="center" colspan="1" rowspan="1">9</td><td align="center" colspan="1" rowspan="1">8.6</td><td align="center" colspan="1" rowspan="1">5</td><td colspan="2" align="center" rowspan="1">8.3</td><td align="center" colspan="1" rowspan="1">4</td><td align="center" colspan="1" rowspan="1">8.8</td><td align="center" colspan="1" rowspan="1">1.000</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Epileptic crisis (hospitalization)</td><td align="center" colspan="1" rowspan="1">4</td><td align="center" colspan="1" rowspan="1">3.8</td><td align="center" colspan="1" rowspan="1">1</td><td colspan="2" align="center" rowspan="1">1.7</td><td align="center" colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">6.6</td><td align="center" colspan="1" rowspan="1">0.311</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Vasospasm</td><td align="center" colspan="1" rowspan="1">40</td><td align="center" colspan="1" rowspan="1">38.1</td><td align="center" colspan="1" rowspan="1">23</td><td colspan="2" align="center" rowspan="1">38.3</td><td align="center" colspan="1" rowspan="1">17</td><td align="center" colspan="1" rowspan="1">37.8</td><td align="center" colspan="1" rowspan="1">0.954</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Vasospasm with invasive treatment<xref rid="tbl2fna" ref-type="table-fn">a</xref></td><td align="center" colspan="1" rowspan="1">27</td><td align="center" colspan="1" rowspan="1">67.5</td><td align="center" colspan="1" rowspan="1">14</td><td colspan="2" align="center" rowspan="1">60.9</td><td align="center" colspan="1" rowspan="1">13</td><td align="center" colspan="1" rowspan="1">76.4</td><td align="center" colspan="1" rowspan="1">0.298</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Sodium disturbances</td><td align="center" colspan="1" rowspan="1">87</td><td align="center" colspan="1" rowspan="1">82.8</td><td align="center" colspan="1" rowspan="1">46</td><td colspan="2" align="center" rowspan="1">76.7</td><td align="center" colspan="1" rowspan="1">41</td><td align="center" colspan="1" rowspan="1">91.1</td><td align="center" colspan="1" rowspan="1">0.68</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Anaemia (admission)</td><td align="center" colspan="1" rowspan="1">44</td><td align="center" colspan="1" rowspan="1">41.9</td><td align="center" colspan="1" rowspan="1">25</td><td colspan="2" align="center" rowspan="1">41.6</td><td align="center" colspan="1" rowspan="1">19</td><td align="center" colspan="1" rowspan="1">42.2</td><td align="center" colspan="1" rowspan="1">0.954</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Anaemia (day 3)</td><td align="center" colspan="1" rowspan="1">83</td><td align="center" colspan="1" rowspan="1">79.0</td><td align="center" colspan="1" rowspan="1">46</td><td colspan="2" align="center" rowspan="1">76.7</td><td align="center" colspan="1" rowspan="1">37</td><td align="center" colspan="1" rowspan="1">82.2</td><td align="center" colspan="1" rowspan="1">0.489</td></tr><tr><td align="left" colspan="1" rowspan="1">ICU and/or NCUU length-of-stay (median (range))</td><td align="center" colspan="1" rowspan="1">23</td><td align="center" colspan="1" rowspan="1">1&#8211;130</td><td align="center" colspan="1" rowspan="1">20</td><td colspan="2" align="center" rowspan="1">1&#8211;85</td><td align="center" colspan="1" rowspan="1">30</td><td align="center" colspan="1" rowspan="1">13&#8211;130</td><td align="center" colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td align="left" colspan="1" rowspan="1">Infirmary length-of-stay (median (range)</td><td align="center" colspan="1" rowspan="1">11</td><td align="center" colspan="1" rowspan="1">0&#8211;159</td><td align="center" colspan="1" rowspan="1">6</td><td colspan="2" align="center" rowspan="1">0&#8211;89</td><td align="center" colspan="1" rowspan="1">19</td><td align="center" colspan="1" rowspan="1">0&#8211;159</td><td align="center" colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td align="left" colspan="1" rowspan="1">mRS &#8804;2&#160;at 1st appointment<xref rid="tbl2fnb" ref-type="table-fn">b</xref></td><td align="center" colspan="1" rowspan="1">54</td><td align="center" colspan="1" rowspan="1">52.9</td><td align="center" colspan="1" rowspan="1">35</td><td colspan="2" align="center" rowspan="1">61.4</td><td align="center" colspan="1" rowspan="1">19</td><td align="center" colspan="1" rowspan="1">40.9</td><td align="center" colspan="1" rowspan="1">0.054</td></tr><tr><td align="left" colspan="1" rowspan="1">mRS &#8804;2&#160;at 2 years<xref rid="tbl2fnc" ref-type="table-fn">c</xref></td><td align="center" colspan="1" rowspan="1">43</td><td align="center" colspan="1" rowspan="1">61.1</td><td align="center" colspan="1" rowspan="1">25</td><td colspan="2" align="center" rowspan="1">65.8</td><td align="center" colspan="1" rowspan="1">18</td><td align="center" colspan="1" rowspan="1">55.8</td><td align="center" colspan="1" rowspan="1">0.389</td></tr><tr><td align="left" colspan="1" rowspan="1">Death</td><td align="center" colspan="1" rowspan="1">12</td><td align="center" colspan="1" rowspan="1">11.4</td><td align="center" colspan="1" rowspan="1">11</td><td colspan="2" align="center" rowspan="1">18.3</td><td align="center" colspan="1" rowspan="1">1</td><td align="center" colspan="1" rowspan="1">2.2</td><td align="center" colspan="1" rowspan="1">0.012</td></tr></tbody></table><table-wrap-foot><fn><p>ICU, intensive care unit; NCCU, neurocritical care unit; mRS, modified Rankin Scale; WFNS, <italic toggle="yes">World Federation of Neurosurgeons;</italic> mFISHER, modified FISHER; sd, standard deviation.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fna"><label>a</label><p id="ntpara0015">n&#160;=&#160;17 for patients with a shunt and n&#160;=&#160;23 for those without.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fnb"><label>b</label><p id="ntpara0020">n&#160;=&#160;44 for patients with a shunt and n&#160;=&#160;57 for those without.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fnc"><label>c</label><p id="ntpara0025">n&#160;=&#160;34 for patients with a shunt and n&#160;=&#160;38 for those without.</p></fn></table-wrap-foot></table-wrap></p><p id="p0110">Regarding initial clinical assessments, 64.5% of patients were admitted to the Neurocritical Care Unit (NCCU) and the rest to the Intensive Care Unit (ICU). The median WFNS score was 4. A higher WFNS score at admission was observed in the VPS group (4 vs 3, p&#160;=&#160;0.045). Dichotomization of the WFNS score revealed that scores of 4 or higher were more predictive of VPS need. Most patients had a mFisher score of 4 and a Hunt and Hess score of 3, with no significant differences between groups.</p><p id="p0115">The majority of the aneurysms were treated with endovascular procedures (47.6%) No significant differences were found between groups or treatment modality, as detailed in <xref rid="tbl2" ref-type="table">Table 2</xref>.</p><p id="p0120">Complications included sodium disturbances and anaemia, with most patients developing anaemia by day 3. Vasospasm, treated invasively in more than half of the cases, occurred similarly in both groups. Patients with VPS placement had longer ICU/NCCU stays (30 vs 20 days, p&#160;&lt;&#160;0,01) and longer infirmary stays (19 vs 6 days, p&#160;&lt;&#160;0,01). Mortality during hospitalization was higher in the non-VPS group (18.3% vs 2.2%, p&#160;=&#160;0.012). 12 patients (11.4%) died during their hospital stay and 6 more (5.7%) died in the subsequent 2-year period. At the first appointment and 2 years after the event, those submitted to VPS placement had similar functional outcomes (mRS &#8804;2&#160;at 1st appointment p&#160;=&#160;0.054, mRS &#8804;2&#160;at 2 years p&#160;=&#160;0.389).</p><p id="p0125">Descriptive analysis of EVD parameters showed that most patients did not undergo weaning attempts and had few failed attempts. However, 45 patients (42.8%) developed EVD infections requiring antibiotic treatment. There were no statistical significant differences regarding EVD output. The duration of EVD placement was longer in individuals with VPS (16 vs 9 days, p&#160;&lt;&#160;0.01). The VPS group also had a higher incidence of infections requiring antibiotics (60% vs 30%, p&#160;=&#160;0.002). Significant differences were also observed in the number of weaning attempts (0 vs 0, p&#160;=&#160;0.004) and failed closure attempts (1 vs 0, p&#160;=&#160;0.002). Dichotomizing these variables revealed that a single failed closure attempt was significantly associated with VPS placement (51.1% vs 23.3%, p&#160;=&#160;0.003), while two or more weaning attempts were necessary to observe significant differences (22.2% vs 3.3%, p&#160;=&#160;0.003). Detailed results are shown in <xref rid="tbl3" ref-type="table">Table 3</xref>.<table-wrap position="float" id="tbl3" orientation="portrait"><label>Table 3</label><caption><p>Analysis of EVD parameters in VPS patients with no VPS patients.</p></caption><alt-text id="alttext0025">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" colspan="1"/><th colspan="2" rowspan="2" align="center">All (n&#160;=&#160;105)<hr/></th><th colspan="4" align="center" rowspan="1">Submitted to VPS placement<hr/></th><th rowspan="3" align="center" colspan="1">P value</th></tr><tr><th colspan="2" align="center" rowspan="1">No (n&#160;=&#160;60)<break/>(n&#160;=&#160;80)<hr/></th><th colspan="2" align="center" rowspan="1">Yes (n&#160;=&#160;45)<break/>(n&#160;=&#160;55)<hr/></th></tr><tr><th align="center" colspan="1" rowspan="1">n</th><th align="center" colspan="1" rowspan="1">%</th><th align="center" colspan="1" rowspan="1">n</th><th align="center" colspan="1" rowspan="1">%</th><th align="center" colspan="1" rowspan="1">n</th><th align="center" colspan="1" rowspan="1">%</th></tr></thead><tbody><tr><td colspan="8" align="left" rowspan="1">EVD parameters</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Day of placement (median (range))</td><td align="center" colspan="1" rowspan="1">1</td><td align="center" colspan="1" rowspan="1">1&#8211;40</td><td align="center" colspan="1" rowspan="1">1</td><td align="center" colspan="1" rowspan="1">1&#8211;8</td><td align="center" colspan="1" rowspan="1">1</td><td align="center" colspan="1" rowspan="1">1&#8211;40</td><td align="center" colspan="1" rowspan="1">0.572</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Total days (median (range))</td><td align="center" colspan="1" rowspan="1">12</td><td align="center" colspan="1" rowspan="1">1&#8211;44</td><td align="center" colspan="1" rowspan="1">9</td><td align="center" colspan="1" rowspan="1">1&#8211;44</td><td align="center" colspan="1" rowspan="1">16</td><td align="center" colspan="1" rowspan="1">2&#8211;40</td><td align="center" colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Mean daily output in the first 72&#160;h (mL, mean&#160;&#177;&#160;sd)</td><td align="center" colspan="1" rowspan="1">226.8</td><td align="center" colspan="1" rowspan="1">(&#177;100.2)</td><td align="center" colspan="1" rowspan="1">213.7</td><td align="center" colspan="1" rowspan="1">(&#177;87,2)</td><td align="center" colspan="1" rowspan="1">244.3</td><td align="center" colspan="1" rowspan="1">(&#177;114,1)</td><td align="center" colspan="1" rowspan="1">0.137</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Mean daily output (mL, mean&#160;&#177;&#160;sd)</td><td align="center" colspan="1" rowspan="1">193.5</td><td align="center" colspan="1" rowspan="1">(&#177;77.0)</td><td align="center" colspan="1" rowspan="1">189.1</td><td align="center" colspan="1" rowspan="1">(&#177;72.1)</td><td align="center" colspan="1" rowspan="1">199.4</td><td align="center" colspan="1" rowspan="1">(&#177;83.7)</td><td align="center" colspan="1" rowspan="1">0.519</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Failed wean tries (median (range))</td><td align="center" colspan="1" rowspan="1">0</td><td align="center" colspan="1" rowspan="1">0&#8211;3</td><td align="center" colspan="1" rowspan="1">0</td><td align="center" colspan="1" rowspan="1">0&#8211;2</td><td align="center" colspan="1" rowspan="1">0</td><td align="center" colspan="1" rowspan="1">0&#8211;3</td><td align="center" colspan="1" rowspan="1">0.004</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;1 failed wean try</td><td align="center" colspan="1" rowspan="1">27</td><td align="center" colspan="1" rowspan="1">25.7</td><td align="center" colspan="1" rowspan="1">17</td><td align="center" colspan="1" rowspan="1">28.3</td><td align="center" colspan="1" rowspan="1">10</td><td align="center" colspan="1" rowspan="1">22.2</td><td align="center" colspan="1" rowspan="1">0.478</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#160;2 failed wean tries</td><td align="center" colspan="1" rowspan="1">12</td><td align="center" colspan="1" rowspan="1">11.4</td><td align="center" colspan="1" rowspan="1">2</td><td align="center" colspan="1" rowspan="1">3.3</td><td align="center" colspan="1" rowspan="1">10</td><td align="center" colspan="1" rowspan="1">22.2</td><td align="center" colspan="1" rowspan="1">0.003</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Total failed closures (median (range))</td><td align="center" colspan="1" rowspan="1">0</td><td align="center" colspan="1" rowspan="1">0&#8211;3</td><td align="center" colspan="1" rowspan="1">0</td><td align="center" colspan="1" rowspan="1">0&#8211;3</td><td align="center" colspan="1" rowspan="1">1</td><td align="center" colspan="1" rowspan="1">0&#8211;3</td><td align="center" colspan="1" rowspan="1">0.002</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;&#8805;&#160;1 Failed closure</td><td align="center" colspan="1" rowspan="1">37</td><td align="center" colspan="1" rowspan="1">35.2</td><td align="center" colspan="1" rowspan="1">14</td><td align="center" colspan="1" rowspan="1">23.3</td><td align="center" colspan="1" rowspan="1">23</td><td align="center" colspan="1" rowspan="1">51.1</td><td align="center" colspan="1" rowspan="1">0.003</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;Dysfunctional EVD</td><td align="center" colspan="1" rowspan="1">33</td><td align="center" colspan="1" rowspan="1">31.4</td><td align="center" colspan="1" rowspan="1">17</td><td align="center" colspan="1" rowspan="1">28.3</td><td align="center" colspan="1" rowspan="1">16</td><td align="center" colspan="1" rowspan="1">35.6</td><td align="center" colspan="1" rowspan="1">0.430</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;EVD infection</td><td align="center" colspan="1" rowspan="1">45</td><td align="center" colspan="1" rowspan="1">42.8</td><td align="center" colspan="1" rowspan="1">18</td><td align="center" colspan="1" rowspan="1">30</td><td align="center" colspan="1" rowspan="1">27</td><td align="center" colspan="1" rowspan="1">60</td><td align="center" colspan="1" rowspan="1">0.002</td></tr></tbody></table><table-wrap-foot><fn><p>EVD, External Ventricular Drainage; sd, standard deviation.</p></fn></table-wrap-foot></table-wrap></p><sec id="sec3.1"><label>3.1</label><title>Predictive model &#8211; SAH-VP</title><p id="p0130">We identified several parameters significantly associated with the need for a VPS, which were included in our predictive model: WFNS score &#8805;4, days with an open EVD, two or more failed weaning attempts, one or more closure attempts and EVD infection. The threshold for the total number of days with an open EVD was determined to be 14 days.</p><p id="p0135">Our binary logistic regression analysis is detailed in <xref rid="tbl4" ref-type="table">Table 4</xref>. To optimize the scoring system, we first normalized the logistic regression coefficients to fit a 1 to 5 scale. This was done by identifying the smallest and largest coefficients and then applying a normalization formula to proportionally scale them, ensuring that each variable's contribution to the outcome was accurately reflected. Each variable was assigned a score from 1 to 5, with higher scores indicating stronger associations with the outcome. This optimal permutation, named the SAH-VP score, achieved the highest AUC of 0,800, with a 95% CI of (0,720&#8211;0,885), indicating excellent performance in predicting shunt dependence and considerable discriminatory ability. The overall model quality was 0,72, reflecting a high fit. <xref rid="fig1" ref-type="fig">Fig. 1</xref> compares the ROC curve of the SAH-VP score with that of the MAGE score.<table-wrap position="float" id="tbl4" orientation="portrait"><label>Table 4</label><caption><p>Selection of predicting variables of VPS through binary logistic regression.</p></caption><alt-text id="alttext0030">Table 4</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Variable</th><th align="center" colspan="1" rowspan="1">B</th><th align="center" colspan="1" rowspan="1">Wald</th><th align="center" colspan="1" rowspan="1">Sig.</th><th align="center" colspan="1" rowspan="1">Exp (B)</th><th align="center" colspan="1" rowspan="1">95% CI for Exp (B)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">WFNS Score &#8805; 4</td><td align="center" colspan="1" rowspan="1">0.335</td><td align="center" colspan="1" rowspan="1">4.337</td><td align="center" colspan="1" rowspan="1">0.037</td><td align="center" colspan="1" rowspan="1">2.731</td><td align="center" colspan="1" rowspan="1">(1175&#8211;10,061)</td></tr><tr><td align="left" colspan="1" rowspan="1">Days with an open EVD &#8805; 14</td><td align="center" colspan="1" rowspan="1">0.265</td><td align="center" colspan="1" rowspan="1">7.057</td><td align="center" colspan="1" rowspan="1">&lt;0,001</td><td align="center" colspan="1" rowspan="1">1.304</td><td align="center" colspan="1" rowspan="1">(1.072&#8211;1.916)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8805; 2 Weaning attempts</td><td align="center" colspan="1" rowspan="1">0.500</td><td align="center" colspan="1" rowspan="1">5.008</td><td align="center" colspan="1" rowspan="1">0,025</td><td align="center" colspan="1" rowspan="1">1.532</td><td align="center" colspan="1" rowspan="1">(1.064&#8211;2.553)</td></tr><tr><td align="left" colspan="1" rowspan="1">Infection of EVD treated with antibiotic</td><td align="center" colspan="1" rowspan="1">0.260</td><td align="center" colspan="1" rowspan="1">4.682</td><td align="center" colspan="1" rowspan="1">0.030</td><td align="center" colspan="1" rowspan="1">1.293</td><td align="center" colspan="1" rowspan="1">(1.025&#8211;1.642)</td></tr><tr><td align="left" colspan="1" rowspan="1">Closure attempts &#8805; 1</td><td align="center" colspan="1" rowspan="1">0.123</td><td align="center" colspan="1" rowspan="1">2.537</td><td align="center" colspan="1" rowspan="1">0.045</td><td align="center" colspan="1" rowspan="1">2.575</td><td align="center" colspan="1" rowspan="1">(0,491&#8211;2938)</td></tr></tbody></table></table-wrap><fig id="fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Comparing the MAGE score with SAH-VP.</p></caption><alt-text id="alttext0010">Fig. 1</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig></p><p id="p0140">We determined that the optimal cut-off point for our score was 5, with a sensitivity of 68.9% and a specificity of 83.1%. Additionally, we assessed the model's goodness-of-fit using the Hosmer-Lemeshow test. The test yielded a chi-square statistic of 4.504, with a p-value of 0.720, suggesting that the model demonstrates good calibration and fits the observed data adequately.</p><p id="p0145">The SAH-VP score includes the following settings, also presented in <xref rid="tbl5" ref-type="table">Table 5</xref>.<list list-type="simple" id="ulist0015"><list-item id="u0030"><label>&#8211;</label><p id="p0150">D<bold>ays with an Open EVD &#8805; 14:</bold> Assigned 0 or 3 points.</p></list-item><list-item id="u0035"><label>&#8211;</label><p id="p0155"><bold>Infection of EVD Treated:</bold> Assigned 0 or 2 points</p></list-item><list-item id="u0040"><label>&#8211;</label><p id="p0160"><bold>2 or more failed weaning attempts:</bold> Assigned 0 or 2 points</p></list-item><list-item id="u0045"><label>&#8211;</label><p id="p0165"><bold>WFNS Score &#8805; 4</bold>: Assigned 0 or 2 points</p></list-item><list-item id="u0050"><label>&#8211;</label><p id="p0170"><bold>1 or more failed closure attempts:</bold> Assigned 0 or 1 point.</p></list-item></list><table-wrap position="float" id="tbl5" orientation="portrait"><label>Table 5</label><caption><p>SAH-VP score.</p></caption><alt-text id="alttext0035">Table 5</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Variable</th><th align="center" colspan="1" rowspan="1">Points</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Days with an Open EVD &#8805; 14</td><td align="center" colspan="1" rowspan="1">3</td></tr><tr><td align="left" colspan="1" rowspan="1">Infection of EVD</td><td align="center" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">Failed weaning attempts &#8805; 2</td><td align="center" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">WFNS Score &#8805; 4</td><td align="center" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">Failed closure attempts &#8805; 2</td><td align="center" colspan="1" rowspan="1">1</td></tr></tbody></table></table-wrap></p><p id="p0175">We subsequently calculated the likelihood of needing VPS based on the scores obtained in our population. The detailed results are presented in <xref rid="tbl6" ref-type="table">Table 6</xref>. When we applied the scoring system to our population, 76% of the cases were identified correctly, and the model achieved a specificity of 84.7% and sensitivity of 64.4%.<table-wrap position="float" id="tbl6" orientation="portrait"><label>Table 6</label><caption><p>Probability of needing VPS for each SAH-VP score.</p></caption><alt-text id="alttext0040">Table 6</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="1" rowspan="1">Score</th><th align="center" colspan="1" rowspan="1">Probability of needing VPS</th></tr></thead><tbody><tr><td align="center" colspan="1" rowspan="1">0</td><td align="center" colspan="1" rowspan="1">10.2%</td></tr><tr><td align="center" colspan="1" rowspan="1">1</td><td align="center" colspan="1" rowspan="1">16.3%</td></tr><tr><td align="center" colspan="1" rowspan="1">2</td><td align="center" colspan="1" rowspan="1">25%</td></tr><tr><td align="center" colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">36.3%</td></tr><tr><td align="center" colspan="1" rowspan="1">4</td><td align="center" colspan="1" rowspan="1">49.4%</td></tr><tr><td align="center" colspan="1" rowspan="1">5</td><td align="center" colspan="1" rowspan="1">62.6%</td></tr><tr><td align="center" colspan="1" rowspan="1">6</td><td align="center" colspan="1" rowspan="1">74.1%</td></tr><tr><td align="center" colspan="1" rowspan="1">7</td><td align="center" colspan="1" rowspan="1">83.1%</td></tr><tr><td align="center" colspan="1" rowspan="1">8</td><td align="center" colspan="1" rowspan="1">89.4%</td></tr><tr><td align="center" colspan="1" rowspan="1">9</td><td align="center" colspan="1" rowspan="1">93.5%</td></tr><tr><td align="center" colspan="1" rowspan="1">10</td><td align="center" colspan="1" rowspan="1">96.1%</td></tr><tr><td align="center" colspan="1" rowspan="1">To sum up:</td><td colspan="1" rowspan="1"/></tr><tr><td align="center" colspan="1" rowspan="1">0&#8211;2</td><td align="center" colspan="1" rowspan="1">&#8804;25%</td></tr><tr><td align="center" colspan="1" rowspan="1">3&#8211;4</td><td align="center" colspan="1" rowspan="1">26&#8211;50%</td></tr><tr><td align="center" colspan="1" rowspan="1">5&#8211;6</td><td align="center" colspan="1" rowspan="1">51&#8211;75%</td></tr><tr><td align="center" colspan="1" rowspan="1">7&#8211;10</td><td align="center" colspan="1" rowspan="1">&gt;80%</td></tr></tbody></table></table-wrap></p></sec><sec id="sec3.2"><label>3.2</label><title>MAGE score</title><p id="p0180">When we applied the MAGE score to our population, we found that the median score was 3, with values ranging from 0 to 5. The shunted group had significantly higher MAGE Scores (3 vs 2, p&#160;=&#160;0.003). To evaluate the discriminatory ability of the MAGE Score, we performed a ROC curve analysis. The AUC was 0,687, with a 95% CI of (0,565&#8211;0,755), indicating fair discriminatory power for predicting the need for VPS. The model's overall fit statistic was 0,58, suggesting that it explains a moderate proportion of the variability in the outcome.</p><p id="p0185">The optimal cut-off point for the MAGE Score was determined to be 3, with a sensitivity of 71.1% and a specificity of 55.0%. The model's goodness-of-fit was further assessed using the Hosmer-Lemeshow test, which yielded a chi-square of 5.692 and a p-value of 0.128, indicating that the model has good calibration and adequately fits the observed data.</p><p id="p0190">We calculated the likelihood of needing a VPS based on the MAGE scores obtained from our population. Detailed results are presented in <xref rid="tbl7" ref-type="table">Table 7</xref>. When we applied the scoring system to our population, 68.6% of the cases were identified correctly, and the model achieved a specificity of 91.7% and sensitivity of 37.8%.<table-wrap position="float" id="tbl7" orientation="portrait"><label>Table 7</label><caption><p>Probability of needing VPS for each MAGE score.</p></caption><alt-text id="alttext0045">Table 7</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="1" rowspan="1">MAGE score</th><th align="center" colspan="1" rowspan="1">Probability of needing VPS</th></tr></thead><tbody><tr><td align="center" colspan="1" rowspan="1">0</td><td align="center" colspan="1" rowspan="1">9.8%</td></tr><tr><td align="center" colspan="1" rowspan="1">1</td><td align="center" colspan="1" rowspan="1">18.1%</td></tr><tr><td align="center" colspan="1" rowspan="1">2</td><td align="center" colspan="1" rowspan="1">31.0%</td></tr><tr><td align="center" colspan="1" rowspan="1">3</td><td align="center" colspan="1" rowspan="1">47.8%</td></tr><tr><td align="center" colspan="1" rowspan="1">4</td><td align="center" colspan="1" rowspan="1">65.1%</td></tr><tr><td align="center" colspan="1" rowspan="1">5</td><td align="center" colspan="1" rowspan="1">79.2%</td></tr><tr><td align="center" colspan="1" rowspan="1">6</td><td align="center" colspan="1" rowspan="1">88.5%</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="sec4"><label>4</label><title>Discussion</title><p id="p0195">Our study aimed to identify and evaluate factors influencing the need for a VPS in patients with aSAH. We found that 36.7% of patients required EVD placement, and 15.7% needed VPS, data consistent with literature (<xref rid="bib43" ref-type="bibr">Wang et al., 2012</xref>; <xref rid="bib44" ref-type="bibr">Weigl et al., 2020</xref>).</p><p id="p0200">The demographic data aligns with existing literature, indicating a higher incidence of the condition in females (75.5%, n&#160;=&#160;79) and increasing incidence with age (mean age at diagnosis&#160;=&#160;63.2&#160;&#177;&#160;14.1) (<xref rid="bib7" ref-type="bibr">De Rooij et al., 2007</xref>; <xref rid="bib10" ref-type="bibr">Etminan et al., 2019</xref>). Most patients had hypertension (54.3%, n&#160;=&#160;57), reinforcing the known link between this disease and SAH (<xref rid="bib45" ref-type="bibr">Ziu et al., 2024</xref>; <xref rid="bib11" ref-type="bibr">Ewbank et al., 2024</xref>; <xref rid="bib25" ref-type="bibr">McGurgan et al., 2019</xref>). Regarding the consequential hydrocephalus, some studies show that age (<xref rid="bib8" ref-type="bibr">Dorai et al., 2003</xref>; <xref rid="bib15" ref-type="bibr">Graff-Radford, 1989</xref>; <xref rid="bib20" ref-type="bibr">Lanzino et al., 1996</xref>; <xref rid="bib38" ref-type="bibr">Tapaninaho et al., 1993</xref>; <xref rid="bib27" ref-type="bibr">Paisan et al., 2018</xref>; <xref rid="bib30" ref-type="bibr">Rincon et al., 2010</xref>) and female sex (<xref rid="bib8" ref-type="bibr">Dorai et al., 2003</xref>; <xref rid="bib38" ref-type="bibr">Tapaninaho et al., 1993</xref>; <xref rid="bib34" ref-type="bibr">Sheehan et al., 1999</xref>; <xref rid="bib3" ref-type="bibr">Chan et al., 2009</xref>) are risk factors for shunt dependency, while ours did not find any significant differences in these factors.</p><p id="p0205">Our study identified the WFNS scale as a significant predictor of VPS need, particularly with scores of 4 or above. The Hunt and Hess and mFISHER scales did not show significant differences, contrasting with other studies (<xref rid="bib8" ref-type="bibr">Dorai et al., 2003</xref>; <xref rid="bib27" ref-type="bibr">Paisan et al., 2018</xref>; <xref rid="bib30" ref-type="bibr">Rincon et al., 2010</xref>; <xref rid="bib3" ref-type="bibr">Chan et al., 2009</xref>; <xref rid="bib2" ref-type="bibr">Akinduro et al., 2020</xref>).</p><p id="p0210">Our study found that aneurysm characteristics, location and treatment type are not strong predictors of shunt dependency in aSAH patients, which is supported by some studies (<xref rid="bib28" ref-type="bibr">Perry et al., 2020</xref>; <xref rid="bib38" ref-type="bibr">Tapaninaho et al., 1993</xref>; <xref rid="bib2" ref-type="bibr">Akinduro et al., 2020</xref>; <xref rid="bib41" ref-type="bibr">Tso et al., 2016</xref>), and contradicted by others (<xref rid="bib44" ref-type="bibr">Weigl et al., 2020</xref>; <xref rid="bib27" ref-type="bibr">Paisan et al., 2018</xref>; <xref rid="bib3" ref-type="bibr">Chan et al., 2009</xref>; <xref rid="bib1" ref-type="bibr">Aboul-Ela et al., 2018</xref>; <xref rid="bib9" ref-type="bibr">Erixon et al., 2014</xref>).</p><p id="p0215">The longer ICU and infirmary stays observed in patients requiring VPS likely reflect the need for more invasive procedures rather than serving as a predictor for VPS placement, since patients requiring more invasive procedures typically experience longer hospitalizations (<xref rid="bib35" ref-type="bibr">Snow et al., 2024</xref>). Vasospasm was a frequent complication in our population. While some studies indicate that vasospasm increases the likelihood of requiring a shunt (<xref rid="bib8" ref-type="bibr">Dorai et al., 2003</xref>; <xref rid="bib27" ref-type="bibr">Paisan et al., 2018</xref>; <xref rid="bib2" ref-type="bibr">Akinduro et al., 2020</xref>), our study, along with others (<xref rid="bib28" ref-type="bibr">Perry et al., 2020</xref>; <xref rid="bib43" ref-type="bibr">Wang et al., 2012</xref>; <xref rid="bib30" ref-type="bibr">Rincon et al., 2010</xref>; <xref rid="bib41" ref-type="bibr">Tso et al., 2016</xref>), found no significant association between vasospasm and VPS dependency.</p><p id="p0220">We found that more patients died in the non-shunted group, as previously described by other studies (<xref rid="bib28" ref-type="bibr">Perry et al., 2020</xref>; <xref rid="bib27" ref-type="bibr">Paisan et al., 2018</xref>). This could be due to more severe conditions or complications that precluded shunt placement in this group.</p><p id="p0225">Our study also found that longer the EVD duration and the number of failed closure or weaning attempts were significant predictors of VPS dependency consistent with the findings of <xref rid="bib28" ref-type="bibr">Perry et al. (2020)</xref>. EVD-related infections increased the likelihood of shunt dependency (<xref rid="bib30" ref-type="bibr">Rincon et al., 2010</xref>; <xref rid="bib41" ref-type="bibr">Tso et al., 2016</xref>; <xref rid="bib32" ref-type="bibr">Sanusi et al., 2020</xref>).</p><p id="p0230">The MAGE score showed moderate ability to distinguish between patients who would need a shunt and those who would not, as indicated by its AUC, and it was well-calibrated. However, our optimised SAH-VP score outperformed the MAGE score, achieving a higher AUC of 0,800 and demonstrating greater sensitivity and specificity, suggesting it is more accurate and useful for clinical decision-making.</p><p id="p0235">When comparing the performance metrics of the two scoring systems, the SAH-VP score demonstrated higher overall accuracy, correctly identifying 76% of cases compared to 68.6% for the MAGE score. The SAH-VP score also achieved a better balance between sensitivity and specificity, with a sensitivity of 64.4% and a specificity of 84.7%. In contrast, the MAGE score showed higher specificity at 91.7% but at the expense of sensitivity, which was notably lower at 37.8%. This indicates that while the MAGE score is more effective at correctly identifying patients who do not require a ventriculoperitoneal shunt, the SAH-VP score is better at identifying those who do, providing a more balanced predictive performance.</p><p id="p0240">The inclusion of variables that were not significant in the MAGE score, such as age (significant only in multivariate analysis) and WFNS score, may have contributed to the improved predictive performance of the SAH-VP score compared to the MAGE score. Contrasting the MAGE score, the WFNS score emerged as a significant predictor in both univariate and multivariate analyses in our study.</p><p id="p0245">Conversely, variables like the mean daily EVD output in the first 72&#160;h, which were significant in both univariate and multivariate analyses in the original study, did not reach significance in our model. This lack of significance may have influenced the predictive accuracy and overall quality of their model within this specific population. The observed discrepancy in the significance of these variables between studies highlights how certain factors can exhibit differing predictive values depending on the population characteristics and clinical context.</p><p id="p0250">It would seem logical that higher thresholds might be better predictors of shunt dependency. However, our findings may indicate that early drainage output alone is a limited predictor of shunt dependency. This highlights the need for more comprehensive research to develop more accurate predictive models that concern EVD parameters.</p><p id="p0255">Despite the valuable insights, our study has limitations, including the retrospective design, which may induce some bias, as the records may not be as accurate, for instance all weaning or closure attempts may not be registered, the EVD volume drainages values may not be as accurate, as they were retrieved retrospectively. Other limitations include the small sample size, potential for residual confounding, and the exclusion of non-EVD patients, which might affect generalizability. Additionally, the observational nature of the study and potential biases due to varying clinician practices could impact the findings. Nevertheless, our study represents a meaningful attempt to improve patient management and outcomes.</p></sec><sec id="sec5"><label>5</label><title>Conclusion</title><p id="p0260">Aneurysmatic SAH is a critical neurological condition that can result in severe complications, such as hydrocephalus. Our analysis reveals that EVD factors are important in predicting shunt dependency. We developed a predictive model that includes several key factors: EVD infection, a WFNS score of 4 or higher, an open EVD for 14 days or more, two or more failed weaning attempts. And one or more failed closure attempts.</p><p id="p0265">Our findings suggest that a SAH-VP score of 5 or higher should be a strong indicator for considering VPS placement. However, further prospective research is needed to provide more reliable and generalizable results for the broader population.</p></sec><sec id="sec6"><title>Funding</title><p id="p0270">This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></sec><sec sec-type="COI-statement"><title>Declaration of competing interest</title><p id="p0275">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name name-style="western"><surname>Aboul-Ela</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Salah El-Din</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Zaater</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Shehab</surname><given-names>M.</given-names></name><name name-style="western"><surname>El Shahawy</surname><given-names>O.A.</given-names></name></person-group><article-title>Predictors of shunt-dependent hydrocephalus following aneurysmal subarachnoid hemorrhage: a pilot study in a single Egyptian institute, Egypt</article-title><source>J. Neurol. Psychiatr. Neurosurg.</source><volume>54</volume><year>2018</year><fpage>11</fpage><pub-id pub-id-type="doi">10.1186/s41983-018-0015-1</pub-id><pub-id pub-id-type="pmcid">PMC5954778</pub-id><pub-id pub-id-type="pmid">29780231</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name name-style="western"><surname>Akinduro</surname><given-names>O.O.</given-names></name><name name-style="western"><surname>Vivas-Buitrago</surname><given-names>T.G.</given-names></name><name name-style="western"><surname>Haranhalli</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ganaha</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mbabuike</surname><given-names>N.</given-names></name><name name-style="western"><surname>Turnbull</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Tawk</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Freeman</surname><given-names>W.D.</given-names></name></person-group><article-title>Predictors of ventriculoperitoneal shunting following subarachnoid hemorrhage treated with external ventricular drainage</article-title><source>Neurocrit. Care</source><volume>32</volume><year>2020</year><fpage>755</fpage><lpage>764</lpage><pub-id pub-id-type="doi">10.1007/s12028-019-00802-8</pub-id><pub-id pub-id-type="pmid">31410771</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alaraj</surname><given-names>A.</given-names></name><name name-style="western"><surname>Calderon</surname><given-names>M.</given-names></name><name name-style="western"><surname>Herrera</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ruland</surname><given-names>S.</given-names></name><name name-style="western"><surname>Roitberg</surname><given-names>B.Z.</given-names></name></person-group><article-title>Prediction of ventriculoperitoneal shunt dependency in patients with aneurysmal subarachnoid hemorrhage: clinical article</article-title><source>JNS</source><volume>110</volume><year>2009</year><fpage>44</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.3171/2008.5.17560</pub-id><pub-id pub-id-type="pmid">18950263</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Reis</surname><given-names>C.</given-names></name><name name-style="western"><surname>Manaenko</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name></person-group><article-title>Hydrocephalus after subarachnoid hemorrhage: pathophysiology, diagnosis, and treatment</article-title><source>BioMed Res. Int.</source><volume>2017</volume><year>2017</year><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1155/2017/8584753</pub-id><pub-id pub-id-type="pmcid">PMC5360938</pub-id><pub-id pub-id-type="pmid">28373987</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>D.Y.</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Rordorf</surname><given-names>G.A.</given-names></name></person-group><article-title>External ventricular drains after subarachnoid hemorrhage: is less more?</article-title><source>Neurocrit. Care</source><volume>28</volume><year>2018</year><fpage>157</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1007/s12028-017-0443-2</pub-id><pub-id pub-id-type="pmid">28929378</pub-id><pub-id pub-id-type="pmcid">PMC5858985</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name name-style="western"><surname>Corbacioglu</surname><given-names>&#350;.</given-names></name><name name-style="western"><surname>Aksel</surname><given-names>G.</given-names></name></person-group><article-title>Receiver operating characteristic curve analysis in diagnostic accuracy studies: a guide to interpreting the area under the curve value</article-title><source>Turk. J. Emerg. Med.</source><volume>23</volume><year>2023</year><fpage>195</fpage><pub-id pub-id-type="doi">10.4103/tjem.tjem_182_23</pub-id><pub-id pub-id-type="pmid">38024184</pub-id><pub-id pub-id-type="pmcid">PMC10664195</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name name-style="western"><surname>De Rooij</surname><given-names>N.K.</given-names></name><name name-style="western"><surname>Linn</surname><given-names>F.H.H.</given-names></name><name name-style="western"><surname>Van Der Plas</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Algra</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rinkel</surname><given-names>G.J.E.</given-names></name></person-group><article-title>Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends</article-title><source>J. Neurol. Neurosurg. Psychiatr.</source><volume>78</volume><year>2007</year><fpage>1365</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1136/jnnp.2007.117655</pub-id><pub-id pub-id-type="pmcid">PMC2095631</pub-id><pub-id pub-id-type="pmid">17470467</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name name-style="western"><surname>Dorai</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Hynan</surname><given-names>L.S.</given-names></name><name name-style="western"><surname>Kopitnik</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Samson</surname><given-names>D.</given-names></name></person-group><article-title>Factors related to hydrocephalus after aneurysmal subarachnoid hemorrhage</article-title><source>Neurosurg.</source><volume>52</volume><year>2003</year><fpage>763</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1227/01.NEU.0000053222.74852.2D</pub-id><pub-id pub-id-type="pmid">12657171</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name name-style="western"><surname>Erixon</surname><given-names>H.O.</given-names></name><name name-style="western"><surname>Sorteberg</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sorteberg</surname><given-names>W.</given-names></name><name name-style="western"><surname>Eide</surname><given-names>P.K.</given-names></name></person-group><article-title>Predictors of shunt dependency after aneurysmal subarachnoid hemorrhage: results of a single-center clinical trial</article-title><source>Acta Neurochir.</source><volume>156</volume><year>2014</year><fpage>2059</fpage><lpage>2069</lpage><pub-id pub-id-type="doi">10.1007/s00701-014-2200-z</pub-id><pub-id pub-id-type="pmid">25143185</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name name-style="western"><surname>Etminan</surname><given-names>N.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>H.-S.</given-names></name><name name-style="western"><surname>Hackenberg</surname><given-names>K.</given-names></name><name name-style="western"><surname>De Rooij</surname><given-names>N.K.</given-names></name><name name-style="western"><surname>Vergouwen</surname><given-names>M.D.I.</given-names></name><name name-style="western"><surname>Rinkel</surname><given-names>G.J.E.</given-names></name><name name-style="western"><surname>Algra</surname><given-names>A.</given-names></name></person-group><article-title>Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis</article-title><source>JAMA Neurol.</source><volume>76</volume><year>2019</year><fpage>588</fpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2019.0006</pub-id><pub-id pub-id-type="pmid">30659573</pub-id><pub-id pub-id-type="pmcid">PMC6515606</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name name-style="western"><surname>Ewbank</surname><given-names>F.</given-names></name><name name-style="western"><surname>Gaastra</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hall</surname><given-names>S.</given-names></name><name name-style="western"><surname>Galea</surname><given-names>I.</given-names></name><name name-style="western"><surname>Bulters</surname><given-names>D.</given-names></name></person-group><article-title>Risk of subarachnoid haemorrhage reduces with blood pressure values below hypertensive thresholds</article-title><source>Eur. J. Neurol.</source><volume>31</volume><year>2024</year><object-id pub-id-type="publisher-id">e16105</object-id><pub-id pub-id-type="doi">10.1111/ene.16105</pub-id><pub-id pub-id-type="pmcid">PMC11236026</pub-id><pub-id pub-id-type="pmid">37877683</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name name-style="western"><surname>Feigin</surname><given-names>V.L.</given-names></name><name name-style="western"><surname>Rinkel</surname><given-names>G.J.E.</given-names></name><name name-style="western"><surname>Lawes</surname><given-names>C.M.M.</given-names></name><name name-style="western"><surname>Algra</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Van Gijn</surname><given-names>J.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>C.S.</given-names></name></person-group><article-title>Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies</article-title><source>Stroke</source><volume>36</volume><year>2005</year><fpage>2773</fpage><lpage>2780</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000190838.02954.e8</pub-id><pub-id pub-id-type="pmid">16282541</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="book" id="sref13"><person-group person-group-type="author"><name name-style="western"><surname>Fowler</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>De Jesus</surname><given-names>O.</given-names></name><name name-style="western"><surname>Mesfin</surname><given-names>F.B.</given-names></name></person-group><part-title>Ventriculoperitoneal shunt</part-title><source>StatPearls</source><year>2024</year><publisher-name>StatPearls Publishing</publisher-name><publisher-loc>Treasure Island (FL)</publisher-loc><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK459351/" id="intref0010">http://www.ncbi.nlm.nih.gov/books/NBK459351/</ext-link></element-citation></ref><ref id="bib14"><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name name-style="western"><surname>Frontera</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Claassen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Wartenberg</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>Temes</surname><given-names>R.</given-names></name><name name-style="western"><surname>Connolly</surname><given-names>E.S.</given-names></name><name name-style="western"><surname>Macdonald</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>S.A.</given-names></name></person-group><article-title>Prediction of symptomatic Vasospasmafter subarachnoid hemorrhage: the modified Fisher scale</article-title><source>Neurosurg.</source><volume>59</volume><year>2006</year><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1227/01.neu.0000243277.86222.6c</pub-id><pub-id pub-id-type="pmid">16823296</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name name-style="western"><surname>Graff-Radford</surname><given-names>N.R.</given-names></name></person-group><article-title>Factors associated with hydrocephalus after subarachnoid hemorrhage: a report of the cooperative aneurysm study</article-title><source>Arch. Neurol.</source><volume>46</volume><year>1989</year><fpage>744</fpage><pub-id pub-id-type="doi">10.1001/archneur.1989.00520430038014</pub-id><pub-id pub-id-type="pmid">2742543</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name name-style="western"><surname>Harrison</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Taquet</surname><given-names>M.</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Watkinson</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Rowland</surname><given-names>M.J.</given-names></name></person-group><article-title>Sex and age effects on risk of non-traumatic subarachnoid hemorrhage: retrospective cohort study of 124,234 cases using electronic health records</article-title><source>J. Stroke Cerebrovasc. Dis.</source><volume>32</volume><year>2023</year><object-id pub-id-type="publisher-id">107196</object-id><pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2023.107196</pub-id><pub-id pub-id-type="pmid">37230056</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name name-style="western"><surname>Hoh</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Ko</surname><given-names>N.U.</given-names></name><name name-style="western"><surname>Amin-Hanjani</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chou</surname><given-names>S.H.-Y.</given-names></name><name name-style="western"><surname>Cruz-Flores</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dangayach</surname><given-names>N.S.</given-names></name><name name-style="western"><surname>Derdeyn</surname><given-names>C.P.</given-names></name><name name-style="western"><surname>Du</surname><given-names>R.</given-names></name><name name-style="western"><surname>H&#228;nggi</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hetts</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Ifejika</surname><given-names>N.L.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>R.</given-names></name><name name-style="western"><surname>Keigher</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Leslie-Mazwi</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Lucke-Wold</surname><given-names>B.</given-names></name><name name-style="western"><surname>Rabinstein</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Robicsek</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Stapleton</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Suarez</surname><given-names>J.I.</given-names></name><name name-style="western"><surname>Tjoumakaris</surname><given-names>S.I.</given-names></name><name name-style="western"><surname>Welch</surname><given-names>B.G.</given-names></name></person-group><article-title>Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American heart association/American stroke association</article-title><source>Stroke</source><volume>54</volume><issue>2023</issue><year>2023</year><pub-id pub-id-type="doi">10.1161/STR.0000000000000436</pub-id><pub-id pub-id-type="pmid">37212182</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name name-style="western"><surname>Hunt</surname><given-names>W.E.</given-names></name><name name-style="western"><surname>Hess</surname><given-names>R.M.</given-names></name></person-group><article-title>Surgical risk as related to time of intervention in the repair of intracranial aneurysms</article-title><source>J. Neurosurg.</source><volume>28</volume><year>1968</year><fpage>14</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.3171/jns.1968.28.1.0014</pub-id><pub-id pub-id-type="pmid">5635959</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="book" id="sref19"><person-group person-group-type="author"><name name-style="western"><surname>Koleva</surname><given-names>M.</given-names></name><name name-style="western"><surname>De Jesus</surname><given-names>O.</given-names></name></person-group><part-title>Hydrocephalus, in: StatPearls</part-title><year>2024</year><publisher-name>StatPearls Publishing</publisher-name><publisher-loc>Treasure Island (FL)</publisher-loc><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK560875/" id="intref0015">http://www.ncbi.nlm.nih.gov/books/NBK560875/</ext-link></element-citation></ref><ref id="bib20"><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name name-style="western"><surname>Lanzino</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kassell</surname><given-names>N.F.</given-names></name><name name-style="western"><surname>Germanson</surname><given-names>T.P.</given-names></name><name name-style="western"><surname>Kongable</surname><given-names>G.L.</given-names></name><name name-style="western"><surname>Truskowski</surname><given-names>L.L.</given-names></name><name name-style="western"><surname>Torner</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Jane</surname><given-names>J.A.</given-names></name></person-group><article-title>__, Age and outcome after aneurysmal subarachnoid hemorrhage: why do older patients fare worse?</article-title><source>J. Neurosurg.</source><volume>85</volume><year>1996</year><fpage>410</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.3171/jns.1996.85.3.0410</pub-id><pub-id pub-id-type="pmid">8751625</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>B.</given-names></name><name name-style="western"><surname>Koyfman</surname><given-names>A.</given-names></name><name name-style="western"><surname>Runyon</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Hemorrhage</surname><given-names>Subarachnoid</given-names></name></person-group><source>Emerg. Med. Clin.</source><volume>35</volume><year>2017</year><fpage>803</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.1016/j.emc.2017.07.001</pub-id><pub-id pub-id-type="pmid">28987430</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name name-style="western"><surname>Macdonald</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Schweizer</surname><given-names>T.A.</given-names></name></person-group><article-title>Spontaneous subarachnoid haemorrhage</article-title><source>Lancet</source><volume>389</volume><year>2017</year><fpage>655</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)30668-7</pub-id><pub-id pub-id-type="pmid">27637674</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name name-style="western"><surname>Maher</surname><given-names>M.</given-names></name><name name-style="western"><surname>Schweizer</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Macdonald</surname><given-names>R.L.</given-names></name></person-group><article-title>Treatment of spontaneous subarachnoid hemorrhage: guidelines and gaps</article-title><source>Stroke</source><volume>51</volume><year>2020</year><fpage>1326</fpage><lpage>1332</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.119.025997</pub-id><pub-id pub-id-type="pmid">31964292</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name name-style="western"><surname>McEvoy</surname><given-names>A.W.</given-names></name></person-group><article-title>Lesson of the week: intracerebral haemorrhage in young adults: the emerging importance of drug misuse</article-title><source>BMJ</source><volume>320</volume><year>2000</year><fpage>1322</fpage><lpage>1324</lpage><pub-id pub-id-type="doi">10.1136/bmj.320.7245.1322</pub-id><pub-id pub-id-type="pmid">10807629</pub-id><pub-id pub-id-type="pmcid">PMC1127314</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name name-style="western"><surname>McGurgan</surname><given-names>I.J.</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>R.</given-names></name><name name-style="western"><surname>Lacey</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kong</surname><given-names>X.L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bian</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lewington</surname><given-names>S.</given-names></name></person-group><article-title>For the China kadoorie biobank consortium, blood pressure and risk of subarachnoid hemorrhage in China</article-title><source>Stroke</source><volume>50</volume><year>2019</year><fpage>38</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.118.022239</pub-id><pub-id pub-id-type="pmid">30580702</pub-id><pub-id pub-id-type="pmcid">PMC6314500</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name name-style="western"><surname>Molyneux</surname><given-names>A.</given-names></name></person-group><article-title>International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial</article-title><source>Lancet</source><volume>360</volume><year>2002</year><fpage>1267</fpage><lpage>1274</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(02)11314-6</pub-id><pub-id pub-id-type="pmid">12414200</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name name-style="western"><surname>Paisan</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Ding</surname><given-names>D.</given-names></name><name name-style="western"><surname>Starke</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Crowley</surname><given-names>R.W.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>K.C.</given-names></name></person-group><article-title>Shunt-Dependent hydrocephalus after aneurysmal subarachnoid hemorrhage: predictors and long-term functional outcomes</article-title><source>Neurosurg.</source><volume>83</volume><year>2018</year><fpage>393</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1093/neuros/nyx393</pub-id><pub-id pub-id-type="pmid">28973194</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name name-style="western"><surname>Perry</surname><given-names>A.</given-names></name><name name-style="western"><surname>Graffeo</surname><given-names>C.S.</given-names></name><name name-style="western"><surname>Kleinstern</surname><given-names>G.</given-names></name><name name-style="western"><surname>Carlstrom</surname><given-names>L.P.</given-names></name><name name-style="western"><surname>Link</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Rabinstein</surname><given-names>A.A.</given-names></name></person-group><article-title>Quantitative modeling of external ventricular drain output to predict shunt dependency in aneurysmal subarachnoid hemorrhage: cohort study</article-title><source>Neurocrit. Care</source><volume>33</volume><year>2020</year><fpage>218</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1007/s12028-019-00886-2</pub-id><pub-id pub-id-type="pmid">31820290</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name name-style="western"><surname>Rekate</surname><given-names>H.L.</given-names></name></person-group><article-title>A contemporary definition and classification of hydrocephalus</article-title><source>Semin. Pediatr. Neurol.</source><volume>16</volume><year>2009</year><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.spen.2009.01.002</pub-id><pub-id pub-id-type="pmid">19410151</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="book" id="sref30"><person-group person-group-type="author"><name name-style="western"><surname>Rincon</surname><given-names>F.</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>E.</given-names></name><name name-style="western"><surname>Starke</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Buitrago</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Fernandez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Claassen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wartenberg</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>Frontera</surname><given-names>J.</given-names></name><name name-style="western"><surname>Seder</surname><given-names>D.B.</given-names></name><name name-style="western"><surname>Palestrant</surname><given-names>D.</given-names></name><name name-style="western"><surname>Connolly</surname><given-names>E.S.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Badjatia</surname><given-names>N.</given-names></name></person-group><series>Predictors of Long-Term Shunt-dependent Hydrocephalus after Aneurysmal Subarachnoid Hemorrhage: Clinical Article, JNS</series><volume>vol. 113</volume><year>2010</year><fpage>774</fpage><lpage>780</lpage><pub-id pub-id-type="doi">10.3171/2010.2.JNS09376</pub-id><pub-id pub-id-type="pmid">20367072</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name name-style="western"><surname>Rinkel</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Van Gijn</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wijdicks</surname><given-names>E.F.</given-names></name></person-group><article-title>Subarachnoid hemorrhage without detectable aneurysm. A review of the causes</article-title><source>Stroke</source><volume>24</volume><year>1993</year><fpage>1403</fpage><lpage>1409</lpage><pub-id pub-id-type="doi">10.1161/01.STR.24.9.1403</pub-id><pub-id pub-id-type="pmid">8362440</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name name-style="western"><surname>Sanusi</surname><given-names>T.D.</given-names></name><name name-style="western"><surname>McLarnon</surname><given-names>M.</given-names></name><name name-style="western"><surname>Abouharb</surname><given-names>A.</given-names></name></person-group><article-title>Risk factors of chronic shunt dependent hydrocephalus following aneurysmal subarachnoid haemorrhage</article-title><source>Clin. Neurol. Neurosurg.</source><volume>198</volume><year>2020</year><object-id pub-id-type="publisher-id">106095</object-id><pub-id pub-id-type="doi">10.1016/j.clineuro.2020.106095</pub-id><pub-id pub-id-type="pmid">32763663</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="book" id="sref33"><person-group person-group-type="author"><name name-style="western"><surname>Shaikh</surname><given-names>N.</given-names></name><name name-style="western"><surname>Chanda</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mohammed</surname><given-names>K.</given-names></name><name name-style="western"><surname>Balfaqih</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mohsin Khan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nahid</surname><given-names>S.</given-names></name><name name-style="western"><surname>Balal</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zubair</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>R.</given-names></name><name name-style="western"><surname>Algallie</surname><given-names>H.</given-names></name><name name-style="western"><surname>Al-Ameri</surname><given-names>G.</given-names></name><name name-style="western"><surname>Thabet</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ayad</surname><given-names>A.</given-names></name></person-group><part-title>Aneurysmal subarachnoid haemorrhage (aSAH) and hydrocephalus: fact and figures</part-title><person-group person-group-type="editor"><name name-style="western"><surname>Lv</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>S.</given-names></name></person-group><source>Frontiers in Hydrocephalus, IntechOpen</source><year>2023</year><pub-id pub-id-type="doi">10.5772/intechopen.110250</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name name-style="western"><surname>Sheehan</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Polin</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Sheehan</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Baskaya</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Kassell</surname><given-names>N.F.</given-names></name></person-group><article-title>Factors associated with hydrocephalus after aneurysmal subarachnoid hemorrhage</article-title><source>Neurosurgery</source><volume>45</volume><year>1999</year><fpage>1120</fpage><lpage>1128</lpage><pub-id pub-id-type="doi">10.1097/00006123-199911000-00021</pub-id><pub-id pub-id-type="pmid">10549928</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name name-style="western"><surname>Snow</surname><given-names>R.</given-names></name><name name-style="western"><surname>Shamshad</surname><given-names>A.</given-names></name><name name-style="western"><surname>Helliwell</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wendell</surname><given-names>L.C.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>B.B.</given-names></name><name name-style="western"><surname>Furie</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Reznik</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Mahta</surname><given-names>A.</given-names></name></person-group><article-title>Predictors of hospital length of stay and long-term care facility placement in aneurysmal subarachnoid hemorrhage</article-title><source>World Neurosurg.: X</source><volume>22</volume><year>2024</year><object-id pub-id-type="publisher-id">100320</object-id><pub-id pub-id-type="doi">10.1016/j.wnsx.2024.100320</pub-id><pub-id pub-id-type="pmcid">PMC10911846</pub-id><pub-id pub-id-type="pmid">38440380</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name name-style="western"><surname>Steinke</surname><given-names>D.</given-names></name><name name-style="western"><surname>Weir</surname><given-names>B.</given-names></name><name name-style="western"><surname>Disney</surname><given-names>L.</given-names></name></person-group><article-title>Hydrocephalus following aneurysmal subarachnoid haemorrhage</article-title><source>Neurol. Res.</source><volume>9</volume><year>1987</year><fpage>3</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1080/01616412.1987.11739764</pub-id><pub-id pub-id-type="pmid">2883603</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name name-style="western"><surname>Sweeney</surname><given-names>K.</given-names></name><name name-style="western"><surname>Silver</surname><given-names>N.</given-names></name><name name-style="western"><surname>Javadpour</surname><given-names>M.</given-names></name></person-group><article-title>Subarachnoid haemorrhage (spontaneous aneurysmal)</article-title><source>Clin. Evid.</source><volume>2016</volume><year>2016</year><fpage>1213</fpage><pub-id pub-id-type="pmcid">PMC4794735</pub-id><pub-id pub-id-type="pmid">26983641</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name name-style="western"><surname>Tapaninaho</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hernesniemi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Vapalahti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Niskanen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kari</surname><given-names>A.</given-names></name><name name-style="western"><surname>Luukkonen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Puranen</surname><given-names>M.</given-names></name></person-group><article-title>Shunt-dependent hydrocephalus after subarachnoid haemorrhage and aneurysm surgery: timing of surgery is not a risk factor</article-title><source>Acta Neurochir.</source><volume>123</volume><year>1993</year><fpage>118</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1007/BF01401866</pub-id><pub-id pub-id-type="pmid">8237488</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name name-style="western"><surname>Teasdale</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Drake</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Hunt</surname><given-names>W.</given-names></name><name name-style="western"><surname>Kassell</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sano</surname><given-names>K.</given-names></name><name name-style="western"><surname>Pertuiset</surname><given-names>B.</given-names></name><name name-style="western"><surname>De Villiers</surname><given-names>J.C.</given-names></name></person-group><article-title>A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies</article-title><source>J. Neurol. Neurosurg. Psychiatr.</source><volume>51</volume><year>1988</year><pub-id pub-id-type="doi">10.1136/jnnp.51.11.1457</pub-id><comment>1457&#8211;1457</comment><pub-id pub-id-type="pmcid">PMC1032822</pub-id><pub-id pub-id-type="pmid">3236024</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name name-style="western"><surname>Togha</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sahraian</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Khorram</surname><given-names>M.</given-names></name><name name-style="western"><surname>Khashayar</surname><given-names>P.</given-names></name></person-group><article-title>Warning signs and symptoms of subarachnoid hemorrhage</article-title><source>South. Med. J.</source><volume>102</volume><year>2009</year><fpage>21</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1097/SMJ.0b013e318188383c</pub-id><pub-id pub-id-type="pmid">19077776</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name name-style="western"><surname>Tso</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Macdonald</surname><given-names>R.L.</given-names></name></person-group><article-title>Predictors of shunt-dependent hydrocephalus following aneurysmal subarachnoid hemorrhage</article-title><source>World Neurosurg.</source><volume>86</volume><year>2016</year><fpage>226</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/j.wneu.2015.09.056</pub-id><pub-id pub-id-type="pmid">26428322</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name name-style="western"><surname>Vivancos</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gilo</surname><given-names>F.</given-names></name><name name-style="western"><surname>Frutos</surname><given-names>R.</given-names></name><name name-style="western"><surname>Maestre</surname><given-names>J.</given-names></name><name name-style="western"><surname>Garc&#237;a-Pastor</surname><given-names>A.</given-names></name><name name-style="western"><surname>Quintana</surname><given-names>F.</given-names></name><name name-style="western"><surname>Roda</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Xim&#233;nez-Carrillo</surname><given-names>A.</given-names></name><name name-style="western"><surname>D&#237;ez Tejedor</surname><given-names>E.</given-names></name><name name-style="western"><surname>Fuentes</surname><given-names>B.</given-names></name><name name-style="western"><surname>Alonso De Leci&#241;ana</surname><given-names>M.</given-names></name><name name-style="western"><surname>&#193;lvarez-Sabin</surname><given-names>J.</given-names></name><name name-style="western"><surname>Arenillas</surname><given-names>J.</given-names></name><name name-style="western"><surname>Calleja</surname><given-names>S.</given-names></name><name name-style="western"><surname>Casado</surname><given-names>I.</given-names></name><name name-style="western"><surname>Castellanos</surname><given-names>M.</given-names></name><name name-style="western"><surname>Castillo</surname><given-names>J.</given-names></name><name name-style="western"><surname>D&#225;valos</surname><given-names>A.</given-names></name><name name-style="western"><surname>D&#237;az-Otero</surname><given-names>F.</given-names></name><name name-style="western"><surname>Egido</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Fern&#225;ndez</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Freijo</surname><given-names>M.</given-names></name><name name-style="western"><surname>G&#225;llego</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gil-N&#250;&#241;ez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Irimia</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lago</surname><given-names>A.</given-names></name><name name-style="western"><surname>Masjuan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mart&#237;-F&#225;bregas</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mart&#237;nez-S&#225;nchez</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mart&#237;nez-Vila</surname><given-names>E.</given-names></name><name name-style="western"><surname>Molina</surname><given-names>C.</given-names></name><name name-style="western"><surname>Morales</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nombela</surname><given-names>F.</given-names></name><name name-style="western"><surname>Purroy</surname><given-names>F.</given-names></name><name name-style="western"><surname>Rib&#243;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rodr&#237;guez-Ya&#241;ez</surname><given-names>M.</given-names></name><name name-style="western"><surname>Roquer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rubio</surname><given-names>F.</given-names></name><name name-style="western"><surname>Segura</surname><given-names>T.</given-names></name><name name-style="western"><surname>Serena</surname><given-names>J.</given-names></name><name name-style="western"><surname>Simal</surname><given-names>P.</given-names></name><name name-style="western"><surname>Tejada</surname><given-names>J.</given-names></name></person-group><article-title>Gu&#237;a de actuaci&#243;n cl&#237;nica en la hemorragia subaracnoidea. Sistem&#225;tica diagn&#243;stica y tratamiento</article-title><source>Neurologia</source><volume>29</volume><year>2014</year><fpage>353</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1016/j.nrl.2012.07.009</pub-id><pub-id pub-id-type="pmid">25649194</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y.-M.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y.-J.</given-names></name><name name-style="western"><surname>Chuang</surname><given-names>M.-J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>T.-H.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>N.-W.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>B.-C.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>W.-C.</given-names></name><name name-style="western"><surname>Su</surname><given-names>B.Y.-J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>T.-M.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>W.-N.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>C.-C.</given-names></name><name name-style="western"><surname>Kung</surname><given-names>C.-T.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>L.-H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.-C.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>C.-H.</given-names></name></person-group><article-title>Predictors and outcomes of shunt-dependent hydrocephalus in patients with aneurysmal sub-arachnoid hemorrhage</article-title><source>BMC Surg.</source><volume>12</volume><year>2012</year><fpage>12</fpage><pub-id pub-id-type="doi">10.1186/1471-2482-12-12</pub-id><pub-id pub-id-type="pmid">22765765</pub-id><pub-id pub-id-type="pmcid">PMC3467164</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name name-style="western"><surname>Weigl</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bruendl</surname><given-names>E.</given-names></name><name name-style="western"><surname>Schoedel</surname><given-names>P.</given-names></name><name name-style="western"><surname>Schebesch</surname><given-names>K.-M.</given-names></name><name name-style="western"><surname>Brawanski</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kieninger</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bele</surname><given-names>S.</given-names><suffix>III</suffix></name></person-group><article-title>Ventricle diameter increase during ventricular drainage challenge &#8211; a predictor of shunt dependency after subarachnoid hemorrhage</article-title><source>J. Clin. Neurosci.</source><volume>72</volume><year>2020</year><fpage>198</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1016/j.jocn.2019.12.011</pub-id><pub-id pub-id-type="pmid">31882364</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="book" id="sref45"><person-group person-group-type="author"><name name-style="western"><surname>Ziu</surname><given-names>E.</given-names></name><name name-style="western"><surname>Khan Suheb</surname><given-names>M.Z.</given-names></name><name name-style="western"><surname>Mesfin</surname><given-names>F.B.</given-names></name></person-group><part-title>Subarachnoid hemorrhage</part-title><source>StatPearls</source><year>2024</year><publisher-name>StatPearls Publishing</publisher-name><publisher-loc>Treasure Island (FL)</publisher-loc><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK441958/" id="intref0020">http://www.ncbi.nlm.nih.gov/books/NBK441958/</ext-link></element-citation></ref></ref-list><sec id="appsec1"><label>Appendix A</label><title>AUC value interpretation (<xref rid="bib6" ref-type="bibr">Corbacioglu and Aksel, 2023</xref>)</title><p id="p0285">
<table-wrap position="anchor" id="undtbl2" orientation="portrait"><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">AUC value</th><th colspan="1" rowspan="1">Test quality</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">0.9&#8211;1.0</td><td align="left" colspan="1" rowspan="1">Excellent</td></tr><tr><td align="left" colspan="1" rowspan="1">0.8&#8211;0.9</td><td align="left" colspan="1" rowspan="1">Considerable</td></tr><tr><td align="left" colspan="1" rowspan="1">0.7&#8211;0.8</td><td align="left" colspan="1" rowspan="1">Fair</td></tr><tr><td align="left" colspan="1" rowspan="1">0.6&#8211;0.7</td><td align="left" colspan="1" rowspan="1">Poor</td></tr><tr><td align="left" colspan="1" rowspan="1">0.5&#8211;0.6</td><td align="left" colspan="1" rowspan="1">Fail</td></tr></tbody></table><table-wrap-foot><fn><p>Adapted from: Corbacioglu &#350;, Aksel G. Receiver operating characteristic curve analysis in diagnostic accuracy studies: A guide to interpreting the area under the curve value. Turk J Emerg Med. 2023; 23(4):195.</p></fn></table-wrap-foot></table-wrap>
</p></sec><ack id="ack0010"><title>Acknowledgements</title><p id="p0280">We would like to express our gratitude to all the participants and medical staff who contributed to this project. Special thanks to our colleagues for their valuable insights and assistance.</p></ack></back></article></pmc-articleset>